Annexon Reports Second Quarter 2026 Financial Results, Business Updates and Key Anticipated Milestones 12 August
Annexon Expands Vonaprument Phase 3 Program in Geographic Atrophy with Addition of Month 24 Dual Primary Endpoint Complementing Month 15 Primary Endpoint and Launch of Open-Label Extension Study 12 August
